Big pharma, Partnering, Pharma

Big pharma giants, Watson & Actavis pharma partners with Par Pharmaceuticals for generic products

Posted on 17 October 2012

Tags: , , ,

Par Pharmaceutical Companies has entered into pharma partners agreements with two well know big pharma companies, Watson Pharmaceuticals and Actavis Group, respectively,to purchase for cash five generic products that are currently marketed in the U.S. .

These generic drugs are marketed by Watson or Actavis, while eight Abbreviated New Drug Applications currently awaiting regulatory approval and a generic product in late-stage development.

The closing of the pharma partners purchase agreements is contingent upon the closing of Watson's acquisition of Actavis.

The five currently marketed products include morphine sulfate extended release capsules, the generic version of Kadian, fentanyl transdermal system CII, the generic equivalent of Duragesic, nifedipine extended release tablets, the generic version of Adalat , diltiazem hydrochloride extended release capsules, the generic equivalent of Cardizem CD, and metoclopramide hydrochloride tablets, the generic version of Reglan.

For further deal information visit Current Agreements (subscription required)

 

Related

Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news- latest deal news for top 50 pharma / big pharma companies

Report: Practical Guide to Finding Partners

Report: Partnering Deals and Alliances with Big Pharma

Report: Partnering Deals and Alliances with Actavis (formerly Watson Pharmaceuticals)

Related reports: Bigpharma Partnering Yearbook 2013

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Print Friendly, PDF & Email

Leave a Reply